Angiosarcoma
📧 Sign up to get email alerts when something new happens for Angiosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-21Clinical Trial Results: Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study [Phase 2]
Phase 2 trial results for sintilimab in locally advanced, metastatic, or recurrent angiosarcoma are posted; the study is terminated.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) [Phase 1, Phase 2]
This is a clinical trial protocol update for NRSTS2021, a Phase 1/2 study evaluating maintenance pazopanib, limited-margin radiation therapy…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma [Phase 2]
Phase 2 clinical trial update of the combination of oleclumab and durvalumab for recurrent, refractory, or metastatic sarcoma, including ang…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors [Phase 2]
This Phase 2 trial update describes testing nivolumab plus ipilimumab in patients with a broad set of rare tumors and notes the study status…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer [Phase 1]
This Clinical Trials Update describes a Phase 1 study of an Fc-engineered anti-CTLA-4 monoclonal antibody by Agenus in patients with advance…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma [Phase 2]
A Phase 2 trial is evaluating intratumoral Vusolimogene Oderparepvec (VO) in combination with Pembrolizumab for angiosarcoma and is currentl…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas [Phase 2]
Phase 2 trial evaluating weekly paclitaxel with or without bevacizumab in metastatic or locally advanced angiosarcoma has completed and repo…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer [Phase 2]
This Clinical Trials update describes the I-SPY TRIAL, a Phase 2 neoadjuvant breast cancer study using personalized adaptive agents; recruit…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients
Clinical trial update describing precision medicine approaches for neoadjuvant therapy in high‑risk sarcoma patients; currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas [NA]
Investigates regorafenib as maintenance therapy after first-line treatment in patients with bone sarcomas and related subtypes. The trial is…
-
CLINICAL_TRIALS withdrawal · 2026-02-13Clinical Trial Update: Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma [Phase 1]
A Phase I trial of TH1 dendritic cell immunotherapy for angiosarcoma has been withdrawn.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors [Phase 1]
This is a Phase 1 clinical trial evaluating the safety, tolerability, and preliminary activity of AGX101 in adults with advanced solid tumor…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS) [Phase 2]
Phase 2 trial evaluating an immuno-oncology combination as first-line treatment for soft tissue sarcomas; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer [Phase 1]
Phase 1 clinical trial evaluating MQ710 with and without pembrolizumab in solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStars
The ProStars study is a prospective observational trial by the Italian Sarcoma Group evaluating localized angiosarcoma at any site. It is cu…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Pembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma Patients [Phase 2]
A Phase 2 clinical trial investigating pembrolizumab plus lenvatinib for unresectable cutaneous angiosarcoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-10Clinical Trial Update: A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures [Phase 4]
A Phase 4 trial evaluating the safety and effectiveness of a Lipiodol Ultra Fluid and glue mixture for embolization procedures in congenital…
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study [Phase 2]
A Phase 2 clinical trial (SiARa Cancer Study) evaluating Sintilimab for locally advanced, metastatic, or recurrent angiosarcoma has been ter…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILE
Describes a descriptive cohort of French patients treated with carbon ion therapy for various cancers, reported outside a PHRC-ETOILE progra…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma [Phase 2]
A Phase 2 trial evaluating MASCT-I in combination with doxorubicin and ifosfamide as first-line therapy for advanced soft tissue sarcoma is …
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: A Phase II Study by Using CICS-1 and SPM-011 Commissioned by CICS and STELLA PHARMA [Phase 2]
A Phase II clinical trial evaluating CICS-1 and SPM-011 for unresectable angiosarcoma, sponsored by Stella Pharma, is currently active but n…
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE) [Phase 2]
Phase 2 clinical trial of eribulin in angiosarcoma and epithelioid hemangioendothelioma has posted results.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Cemiplimab for Secondary Angiosarcomas [Phase 2]
This report indicates the completion of a Phase 2 trial evaluating cemiplimab for secondary angiosarcoma and related locally advanced or met…
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: Albumin-bound Paclitaxel Combined With Liposomal Doxorubicin in the Treatment of Advanced or Unresectable Angiosarcoma [Phase 2]
Phase 2 trial evaluating albumin-bound paclitaxel with liposomal doxorubicin for advanced or unresectable angiosarcoma.
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Propranolol in Angiosarcoma [Phase 2]
Phase 2 clinical trial investigating propranolol for angiosarcoma has completed.